Skip to main content
Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.680
-0.110 (-6.15%)
At close: Nov 13, 2026, 4:00 PM EST
1.850
+0.170 (10.12%)
After-hours: Nov 13, 2026, 6:48 PM EST

Ernexa Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.580.07--
Revenue Growth
--755.88%---
Gross Profit
--0.49-0.17--
Operating Income
-12.8-9.32-17.25-20.68-27.23-27.43
Net Income
-13.97-14.1-44.56-21.68-24.6-122.56
Earnings Per Share
-14.93-55.89-1224.04-1530.17--
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5.581.881.737.5811.4516.99
Total Debt
0.310.490.6841.841.182.72
Net Cash (Debt)
5.271.391.05-34.2710.2614.26
Net Cash Growth
111.06%33.40%---28.03%-
Net Cash Per Share
5.625.5328.71-2418.18--

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.73-7.02-15.84-20.41-20.98-23.49
Capital Expenditures
-0.02-0.04-0.37-0.02-0.3-0.15
Free Cash Flow
-10.75-7.05-16.21-20.43-21.27-23.64
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--83.50%-247.06%--
Operating Margin
---2963.92%-30404.41%--
Pretax Margin
---7647.59%-31869.12%--
Profit Margin
---7655.50%-31888.23%--
FCF Margin
---2784.36%-30039.71%--

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--25.95142.81--